The Mary Kay Foundation recently granted $1.3 million collectively to 13 medical scientists and doctors to research and develop new treatments for breast and other hereditary cancers that affect women. Altogether, this $1.3 million effort supports the Mary Kay Foundation's work to reduce the impact of deadly illnesses that target one in three women, according to data from the American Cancer Society.

"We are committed to eliminating cancers affecting women by supporting top medical scientists who are searching for a cure for breast, uterine, cervical and ovarian cancers," said executive director of the Mary Kay Museum Jennifer Cook. "Providing options to women who are suffering from cancer and saving their lives brings us one step closer to eliminating cancer."

This year's grant recipients include Deric Wheeler of the Wisconsin Institute for Medical Research, who is working on a project that enhances triple-negative breast cancer cetuximab therapy, David Sherr of Boston University Medical Center for triple negative and chemo-resistant breast cancer therapy and William Hahn of the Dana-Farber Cancer Institute at Harvard for his work on breast cancer's effects on the genomic characterization of brain metastases.

Organizations providing funds to multiple nonprofit programs might find it easier to manage their large-scale efforts with fundraising management programs that can account for funds as they are disbursed to recipients.